CVS Health Ventures
VC Fund
Woonsocket, United States
CVS Health Ventures is a dedicated corporate venture capital fund that invests in and partners with high-potential, early-stage companies that strive to make health care more accessible, affordable, and better.
- Total investments:
- 42
- Last investment:
- Lead investor:
- 36%
Last updated:
For AI agents: llms.txt
Industries CVS Health Ventures invests in
Stages CVS Health Ventures invests in
Countries CVS Health Ventures invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Alyssa Reisner
|
|||
Michael Pimental
|
|||
Vijay Patel
|
|||
2 more contacts available
Investment Focus
Industry
- Health Care 27 (64%)
- Medical 14 (33%)
- Artificial Intelligence 7 (17%)
- Wellness 4 (10%)
- Therapeutics 4 (10%)
Stage
- Series C 9 (21%)
- Series D 8 (19%)
- Series A 7 (17%)
- Series B 6 (14%)
- Venture - Series Unknown 5 (12%)
Country
- United States 28 (67%)
- Israel 1 (2%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Alyssa Reisner
Lead Director and Investment Principal
|
Lead Director and Investment Principal | Total investments: 5 | Find email | |
|
Michael Pimental
Co-Founder & Partner
|
Co-Founder & Partner | Total investments: 0 | Find email | |
|
Vijay Patel
Co-Founder & Partner
|
Co-Founder & Partner | Total investments: 15 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Simile
|
Simile is an artificial intelligence company that provides a platform for automating and improving communication and collaboration through AI-driven tools. It offers solutions for creating and managing conversations, generating content, and analyzing interactions to support business workflows. The company integrates AI models to assist teams indrafting messages, responding to queries, and enhancing productivity across digital communication channels. Its platform combines natural language processing, automation, and data analysis to streamline communication tasks and improve organizational efficiency. | $200M / Series B / Jul 30, 2026 | |
H1.co
|
H1 is an AI-powered platform that helps identify and engage the right doctors for critical workflows across pharma, health plan, health system, and technology companies. At the core of the platform is H1’s Doctor Graph—a structured representation of physician identity, expertise, relationships, and behavioral signals, creating a powerful networkeffect as it is continuously enriched by participants across the healthcare ecosystem. Built on one of the world’s largest and most comprehensive global datasets of healthcare professionals, H1 combines deep healthcare data with agentic AI workflows to power critical workflows across drug development, medical and commercial engagement, care navigation, and provider data and network intelligence. Founded in 2017, the company is based in New York, United States. | $40M / Series D / May 28, 2026 | |
Fathom
|
Fathom develops a coding automation platform that uses artificial intelligence to automatically review incoming charts and offers full-service coding services and comprehensive real-time audits, enabling medical operators to automate their coding and optimize their business. | Venture - Series Unknown / May 04, 2026 | |
Big Health
|
Big Health is a digital therapeutics company that operates a digital healthcare portal to offer fully-automated and highly personalized digital therapeutics and behavioral programs for mental health issues. Its portal offers an online personalized medicine-care and prepares a sleep improvement program in consultation with medical professionals thatenable individuals to overcome their sleep-related disorders in an efficient manner. | $23.7M / Venture - Series Unknown / Feb 12, 2026 | |
Codoxo
|
Codoxo uses AI technology to re-envision healthcare affordability and effectiveness. Its Forensic AI Platform uses a patented algorithm to identify problems and suspicious behavior earlier than traditional techniques which helps ensure our scarce healthcare dollars go to real patient care. It was founded in 2016 and is based in Atlanta, Georgia. | $35M / Series C / Dec 17, 2025 | |
knownwell
|
knownwell is on metabolic health and obesity medicine. It touts itself as a healthcare provider that serves people of all sizes. It provides primary care, nutritional advice, behavioral health treatments, and services for metabolic health. | $25M / Series B / Oct 20, 2025 | |
Thyme Care
|
Thyme Care is a healthcare company that provides oncology care management services. The company offers a patient- and provider-integrated oncology solution, partnering with health plans to facilitate whole-person care for their members. Thyme Care seeks to revolutionize cancer care by providing personalized and holistic support to patients. Thecompany envisions a future where every cancer patient can access high-quality, individualized care that meets their unique needs and circumstances. | $97M / Series D / Sep 25, 2025 | |
|
Thyme Care
|
Thyme Care is a healthcare company that provides oncology care management services. The company offers a patient- and provider-integrated oncology solution, partnering with health plans to facilitate whole-person care for their members. Thyme Care seeks to revolutionize cancer care by providing personalized and holistic support to patients. Thecompany envisions a future where every cancer patient can access high-quality, individualized care that meets their unique needs and circumstances. | $97M / Series D / Sep 25, 2025 | |
AmplifAI
|
At AmplifAI, we’re applying science to make teams better. AmplifAI was founded with the goal of leveraging data to create a personalized environment that enables every employee to succeed. As more companies explore the new generation of hybrid work, innovative leaders and organizations are relying on AmplifAI to enable performance, improve peopleand make work more fun – wherever work is happening. Visit https://www.amplifai.com to learn more. | $33.7M / Series B / Sep 23, 2025 | |
Strive Health
|
Strive Health is a built-for-purpose company working with innovative payers and providers to transform kidney care. Strive Health significantly improves patient outcomes and experience with a high-touch, technology-enabled clinical model that cares for chronic kidney disease patients across their entire healthcare journey, from primary care-levelengagement through dialysis.Strive was launched out of Oxeon’s Venture Studio and is backed by New Enterprise Associates, Town Hall Ventures, Echo Health Ventures, and Ascension Ventures. | $300M / Series D / Sep 09, 2025 | |
| See all 42 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does CVS Health Ventures invest in?
CVS Health Ventures invests primarily in Health Care, Medical and Artificial Intelligence startups, most often at Series C and Series D stage. Most of the 42 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact CVS Health Ventures?
Public channels for CVS Health Ventures include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at CVS Health Ventures?
The team at CVS Health Ventures includes Alyssa Reisner (Lead Director and Investment Principal), Michael Pimental (Co-Founder & Partner) and Vijay Patel (Co-Founder & Partner). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
